US Stock MarketDetailed Quotes

AMPH Amphastar Pharmaceuticals

Watchlist
  • 28.290
  • +0.380+1.36%
Close Mar 21 16:00 ET
  • 28.610
  • +0.320+1.13%
Post 20:01 ET
1.35BMarket Cap9.25P/E (TTM)

Amphastar Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
16.28%213.39M
21.62%29.02M
-6.80%59.96M
25.83%69.11M
36.92%55.29M
105.76%183.5M
56.73%23.86M
215.75%64.33M
1,851.08%54.92M
-20.45%40.38M
Net income from continuing operations
15.98%159.52M
4.97%37.96M
-17.86%40.43M
45.26%37.95M
65.86%43.18M
50.51%137.55M
6.65%36.17M
210.08%49.22M
50.61%26.12M
7.34%26.03M
Operating gains losses
-128.38%-2.21M
-164.03%-4.39M
334.48%6.09M
-93.56%164K
-514.66%-4.07M
986.79%7.79M
933.94%6.86M
-295.13%-2.6M
-12.54%2.55M
142.53%982K
Depreciation and amortization
36.93%57.21M
6.35%14.66M
6.35%14.43M
101.47%14.15M
88.79%13.96M
47.75%41.78M
88.22%13.79M
85.27%13.57M
2.81%7.02M
8.84%7.4M
Deferred tax
-23.62%-16.98M
----
----
----
----
12.79%-13.74M
----
----
----
----
Other non cash items
-47.08%6.03M
-75.15%724K
-85.79%744K
-23.64%2.44M
3,506.78%2.13M
2,346.14%11.4M
9,610.00%2.91M
2,046.31%5.24M
--3.19M
--59K
Change In working capital
39.91%-14.55M
67.88%-8.59M
-27.56%-7.33M
1.85%8.64M
-3,569.19%-7.27M
24.76%-24.21M
-94.17%-26.75M
14.40%-5.74M
129.54%8.48M
-101.16%-198K
-Change in receivables
16.92%-21.67M
-28.93%2.91M
58.99%-8.06M
428.82%6.68M
-96.69%-23.2M
-157.46%-26.09M
135.39%4.09M
-645.46%-19.64M
116.24%1.26M
-310.72%-11.8M
-Change in inventory
-2,730.45%-48.8M
-608.37%-24.47M
-26.67%-7.31M
-578.74%-7.03M
-3,829.48%-10M
85.32%-1.72M
309.27%4.81M
-4.91%-5.77M
78.14%-1.04M
109.97%268K
-Change in prepaid assets
-293.18%-10.73M
91.63%-237K
-1,589.76%-10.73M
-16.89%433K
-187.67%-192K
-47.14%-2.73M
11.36%-2.83M
-172.65%-635K
154.73%521K
-84.58%219K
-Change in payables and accrued expense
380.19%63.56M
162.34%2.11M
208.02%24.65M
341.46%13.73M
318.53%23.08M
1,898.51%13.24M
75.06%-3.39M
2,803.38%8M
-15.97%3.11M
-41.60%5.51M
-Change in other current liabilities
-4.49%-3.75M
4.12%-884K
-5.56%-968K
-7.09%-951K
-9.86%-947K
-13.79%-3.59M
-8.34%-922K
-9.82%-917K
-14.88%-888K
-24.03%-862K
-Change in other working capital
305.91%6.83M
142.03%11.98M
-137.17%-4.91M
-176.72%-4.23M
-38.19%3.99M
27.14%-3.32M
-300.25%-28.5M
390.25%13.22M
130.33%5.51M
64.52%6.46M
Cash from discontinued investing activities
Operating cash flow
16.28%213.39M
21.62%29.02M
-6.80%59.96M
25.83%69.11M
36.92%55.29M
105.76%183.5M
56.73%23.86M
215.75%64.33M
1,851.08%54.92M
-20.45%40.38M
Investing cash flow
Cash flow from continuing investing activities
80.75%-124.93M
65.38%-35.68M
-11.02%-34.59M
86.26%-69.9M
340.60%15.24M
-1,880.40%-649.12M
-44,899.56%-103.05M
-104.17%-31.15M
-6,117.38%-508.58M
30.48%-6.33M
Net PPE purchase and sale
-7.53%-41.04M
-31.44%-12.41M
-35.32%-13.79M
33.24%-6.04M
7.22%-8.79M
-61.63%-38.17M
-49.64%-9.44M
-81.27%-10.19M
-63.40%-9.05M
-54.37%-9.48M
Net business purchase and sale
74.53%-129M
--0
--0
----
----
---506.41M
--0
---5.58M
----
----
Net investment purchase and sale
146.47%49.23M
76.29%-21.8M
-1.85%-19.74M
2,888.67%66.74M
664.31%24.03M
-1,259.52%-105.93M
-1,357.46%-91.93M
-104.19%-19.38M
178.88%2.23M
213.01%3.14M
Net other investing changes
-396.33%-4.12M
12.43%-1.47M
-126.45%-1.06M
----
----
201.31%1.39M
-36.10%-1.67M
2,855.86%4M
----
----
Cash from discontinued investing activities
Investing cash flow
80.75%-124.93M
65.38%-35.68M
-11.02%-34.59M
86.26%-69.9M
340.60%15.24M
-1,880.40%-649.12M
-44,899.56%-103.05M
-104.17%-31.15M
-6,117.38%-508.58M
30.48%-6.33M
Financing cash flow
Cash flow from continuing financing activities
-117.83%-80.95M
28.12%-33.84M
-126.34%-22.82M
-102.50%-10.72M
-0.23%-13.58M
1,817.51%454.09M
-191.31%-47.08M
721.72%86.61M
43,169.52%428.11M
-391.48%-13.55M
Net issuance payments of debt
-98.07%10.17M
109.48%4.75M
-93.47%9.47M
-101.86%-8.03M
511.57%3.98M
29,653.17%526.34M
-39,081.25%-50.15M
27,863.60%144.93M
73,040.30%432.54M
-79.93%-968K
Net common stock issuance
-46.98%-85.46M
---42M
30.09%-34.96M
-6,539.06%-8.5M
--0
-45.69%-58.14M
--0
-244.98%-50M
97.91%-128K
-552.16%-8.02M
Proceeds from stock option exercised by employees
-144.19%-4.85M
-4.92%3.39M
53.43%3.26M
-40.98%5.82M
-279.21%-17.31M
-29.91%10.97M
74.68%3.56M
51.86%2.13M
70.38%9.85M
-170.92%-4.57M
Net other financing activities
96.75%-816K
104.48%22K
94.38%-587K
--1K
---252K
-6,061.92%-25.08M
-16,266.67%-491K
-3,213.65%-10.44M
----
----
Cash from discontinued financing activities
Financing cash flow
-117.83%-80.95M
28.12%-33.84M
-126.34%-22.82M
-102.50%-10.72M
-0.23%-13.58M
1,817.51%454.09M
-191.32%-47.08M
721.73%86.61M
43,169.52%428.11M
-391.48%-13.55M
Net cash flow
Beginning cash position
-7.55%144.53M
-29.03%192.35M
25.50%189.85M
13.87%201.38M
-7.55%144.53M
23.50%156.33M
72.11%271.04M
-9.08%151.28M
2.31%176.85M
23.50%156.33M
Current changes in cash
165.13%7.5M
67.93%-40.5M
-97.86%2.56M
54.95%-11.51M
177.79%56.95M
-138.44%-11.52M
-10,738.45%-126.27M
1,459.14%119.8M
-301.76%-25.55M
-55.72%20.5M
Effect of exchange rate changes
32.62%-190K
95.38%-11K
-65.79%-63K
13.64%-19K
-706.25%-97K
-28.18%-282K
-1,352.63%-238K
61.62%-38K
80.18%-22K
155.17%16K
End cash Position
5.06%151.84M
5.06%151.84M
-29.03%192.35M
25.50%189.85M
13.87%201.38M
-7.55%144.53M
-7.55%144.53M
72.11%271.04M
-9.08%151.28M
2.31%176.85M
Free cash flow
18.58%172.35M
15.19%16.61M
-14.72%46.17M
37.49%63.07M
50.45%46.5M
123.09%145.34M
61.75%14.42M
267.01%54.14M
1,557.55%45.87M
-30.75%30.91M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 16.28%213.39M21.62%29.02M-6.80%59.96M25.83%69.11M36.92%55.29M105.76%183.5M56.73%23.86M215.75%64.33M1,851.08%54.92M-20.45%40.38M
Net income from continuing operations 15.98%159.52M4.97%37.96M-17.86%40.43M45.26%37.95M65.86%43.18M50.51%137.55M6.65%36.17M210.08%49.22M50.61%26.12M7.34%26.03M
Operating gains losses -128.38%-2.21M-164.03%-4.39M334.48%6.09M-93.56%164K-514.66%-4.07M986.79%7.79M933.94%6.86M-295.13%-2.6M-12.54%2.55M142.53%982K
Depreciation and amortization 36.93%57.21M6.35%14.66M6.35%14.43M101.47%14.15M88.79%13.96M47.75%41.78M88.22%13.79M85.27%13.57M2.81%7.02M8.84%7.4M
Deferred tax -23.62%-16.98M----------------12.79%-13.74M----------------
Other non cash items -47.08%6.03M-75.15%724K-85.79%744K-23.64%2.44M3,506.78%2.13M2,346.14%11.4M9,610.00%2.91M2,046.31%5.24M--3.19M--59K
Change In working capital 39.91%-14.55M67.88%-8.59M-27.56%-7.33M1.85%8.64M-3,569.19%-7.27M24.76%-24.21M-94.17%-26.75M14.40%-5.74M129.54%8.48M-101.16%-198K
-Change in receivables 16.92%-21.67M-28.93%2.91M58.99%-8.06M428.82%6.68M-96.69%-23.2M-157.46%-26.09M135.39%4.09M-645.46%-19.64M116.24%1.26M-310.72%-11.8M
-Change in inventory -2,730.45%-48.8M-608.37%-24.47M-26.67%-7.31M-578.74%-7.03M-3,829.48%-10M85.32%-1.72M309.27%4.81M-4.91%-5.77M78.14%-1.04M109.97%268K
-Change in prepaid assets -293.18%-10.73M91.63%-237K-1,589.76%-10.73M-16.89%433K-187.67%-192K-47.14%-2.73M11.36%-2.83M-172.65%-635K154.73%521K-84.58%219K
-Change in payables and accrued expense 380.19%63.56M162.34%2.11M208.02%24.65M341.46%13.73M318.53%23.08M1,898.51%13.24M75.06%-3.39M2,803.38%8M-15.97%3.11M-41.60%5.51M
-Change in other current liabilities -4.49%-3.75M4.12%-884K-5.56%-968K-7.09%-951K-9.86%-947K-13.79%-3.59M-8.34%-922K-9.82%-917K-14.88%-888K-24.03%-862K
-Change in other working capital 305.91%6.83M142.03%11.98M-137.17%-4.91M-176.72%-4.23M-38.19%3.99M27.14%-3.32M-300.25%-28.5M390.25%13.22M130.33%5.51M64.52%6.46M
Cash from discontinued investing activities
Operating cash flow 16.28%213.39M21.62%29.02M-6.80%59.96M25.83%69.11M36.92%55.29M105.76%183.5M56.73%23.86M215.75%64.33M1,851.08%54.92M-20.45%40.38M
Investing cash flow
Cash flow from continuing investing activities 80.75%-124.93M65.38%-35.68M-11.02%-34.59M86.26%-69.9M340.60%15.24M-1,880.40%-649.12M-44,899.56%-103.05M-104.17%-31.15M-6,117.38%-508.58M30.48%-6.33M
Net PPE purchase and sale -7.53%-41.04M-31.44%-12.41M-35.32%-13.79M33.24%-6.04M7.22%-8.79M-61.63%-38.17M-49.64%-9.44M-81.27%-10.19M-63.40%-9.05M-54.37%-9.48M
Net business purchase and sale 74.53%-129M--0--0-----------506.41M--0---5.58M--------
Net investment purchase and sale 146.47%49.23M76.29%-21.8M-1.85%-19.74M2,888.67%66.74M664.31%24.03M-1,259.52%-105.93M-1,357.46%-91.93M-104.19%-19.38M178.88%2.23M213.01%3.14M
Net other investing changes -396.33%-4.12M12.43%-1.47M-126.45%-1.06M--------201.31%1.39M-36.10%-1.67M2,855.86%4M--------
Cash from discontinued investing activities
Investing cash flow 80.75%-124.93M65.38%-35.68M-11.02%-34.59M86.26%-69.9M340.60%15.24M-1,880.40%-649.12M-44,899.56%-103.05M-104.17%-31.15M-6,117.38%-508.58M30.48%-6.33M
Financing cash flow
Cash flow from continuing financing activities -117.83%-80.95M28.12%-33.84M-126.34%-22.82M-102.50%-10.72M-0.23%-13.58M1,817.51%454.09M-191.31%-47.08M721.72%86.61M43,169.52%428.11M-391.48%-13.55M
Net issuance payments of debt -98.07%10.17M109.48%4.75M-93.47%9.47M-101.86%-8.03M511.57%3.98M29,653.17%526.34M-39,081.25%-50.15M27,863.60%144.93M73,040.30%432.54M-79.93%-968K
Net common stock issuance -46.98%-85.46M---42M30.09%-34.96M-6,539.06%-8.5M--0-45.69%-58.14M--0-244.98%-50M97.91%-128K-552.16%-8.02M
Proceeds from stock option exercised by employees -144.19%-4.85M-4.92%3.39M53.43%3.26M-40.98%5.82M-279.21%-17.31M-29.91%10.97M74.68%3.56M51.86%2.13M70.38%9.85M-170.92%-4.57M
Net other financing activities 96.75%-816K104.48%22K94.38%-587K--1K---252K-6,061.92%-25.08M-16,266.67%-491K-3,213.65%-10.44M--------
Cash from discontinued financing activities
Financing cash flow -117.83%-80.95M28.12%-33.84M-126.34%-22.82M-102.50%-10.72M-0.23%-13.58M1,817.51%454.09M-191.32%-47.08M721.73%86.61M43,169.52%428.11M-391.48%-13.55M
Net cash flow
Beginning cash position -7.55%144.53M-29.03%192.35M25.50%189.85M13.87%201.38M-7.55%144.53M23.50%156.33M72.11%271.04M-9.08%151.28M2.31%176.85M23.50%156.33M
Current changes in cash 165.13%7.5M67.93%-40.5M-97.86%2.56M54.95%-11.51M177.79%56.95M-138.44%-11.52M-10,738.45%-126.27M1,459.14%119.8M-301.76%-25.55M-55.72%20.5M
Effect of exchange rate changes 32.62%-190K95.38%-11K-65.79%-63K13.64%-19K-706.25%-97K-28.18%-282K-1,352.63%-238K61.62%-38K80.18%-22K155.17%16K
End cash Position 5.06%151.84M5.06%151.84M-29.03%192.35M25.50%189.85M13.87%201.38M-7.55%144.53M-7.55%144.53M72.11%271.04M-9.08%151.28M2.31%176.85M
Free cash flow 18.58%172.35M15.19%16.61M-14.72%46.17M37.49%63.07M50.45%46.5M123.09%145.34M61.75%14.42M267.01%54.14M1,557.55%45.87M-30.75%30.91M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+5.27%
Apple
AAPL
+1.95%
Meta Platforms
META
+1.75%
Microsoft
MSFT
+1.14%
Petroleo Brasileiro SA Petrobras
PBR
+0.93%

Unlock the Full List